MycAway™ Mycoplasma Real-time qPCR Detection Kit (2G) _ 40619ES

ذخیره کنید $125.00
YeasenSKU: 40619ES25

Size: 25 T
قیمت:
قیمت فروش$625.00 قیمت منظم$750.00

حمل و نقل محاسبه شده است در پرداخت

انبار:
در انبار

شرح

MycAway™ Mycoplasma Real-time qPCR Detection Kit (2G) is a product which can qualitative detect the mycoplasma contamination in the raw materials, cell bank, virus seeds, virual or cell harvesting solution and cells used in clinical treatment, etc. The kit uses the Taqman fluorescent probe (which included FAM and CY5) and the Multiple polymerase chain reaction (PCR) tools to detect the target and internal control separately. It covered over 183 species of the Mollicutes DNA, the specificity, detection limit and robustness of this kit are validated according to EP2.6.7 which with high sensitivity, specificity, efficiency and safety. The detection limit is equals to and below 10 CFU/mL.

This product can be used in combination with Magnetic Residual DNA Sample Preparation Kit (Cat#18461ES/18469) which using the manual extracted method for the nucleic acid extraction. (Please note, the kits which included Cat#18461ES and Cat#40619ES are full validated, please contact our technical support for detailed validation information). After the samples are pre-treated to remove the interference impurities and obtain purified nucleic acid, then a qPCR reaction perform by the Real Time PCR amplifier and the fluorescence signal of the probe will be collected and analyzed.

Features

Broad Detection Range: Optimized TaqMan probes detect up to 183 mycoplasma species.

Fast & Convenient: Sample prep and testing completed in under 3 hours, versus 28 days for culture(Alternative to the standard 28-day culture test).

High Sensitivity: Detects as low as 10 CFU/mL, making it a reliable alternative to culture methods.

High Specificity: 16S rRNA-based primers and probes avoid cross-reactivity with related species such as Clostridium and Sesamum.

Safe to Use: Non-infectious positive control eliminates contamination risk.

Strong Anti-Interference: Internal control (IC) detects sample inhibition or reaction errors, reducing false negatives.

Regulatory Compliance: Validated according to the requirements of EP2.6.7, JP G3 and USP 63 pharmacopoeia, in line with the standards of international authorities.

 Validation Report

Specifications

Sample Type

media, cells, raw materials;

Biopharmaceutical Purification Sample, Bulk Drug Substance Sample, Cell Cultures.

Detect method

qPCR method(Taqman fluorescent)

Detect Time

<4 hours

Fluorescent probe

FAM(Target channel);VIC(Internal channel)

Pretreatment kit

Compatible with magnetic bead-based sample pretreatment kits(Cat#18461/18469)

Applicable Models

Thermo: ABI7500, ABI QuantStudio™ 5; Roche: LC 480; Bio-Rad:CFX96 Optic Module

Detection Limit(LOD)

10 CFU/mL

Covered mycoplasma

183 mycoplasma species

Validation

Validated according to EP <2.6.7>

Components

Components No.

Name

40619ES25

40619ES60

40619-A

2×MyqPCR Reaction Buffer

375 μL

1.5 mL

40619-B

MyPrimer & Probe Mix

100 μL

400 μL

40619-C*

Internal Control (IC)

25 μL

100 μL

40619-D**

Positive Control (PCS)

250 μL

1 mL

40619-E***

DNA Dilution buffer

500 μL

2×1 mL

40619-F****

Ultrapure water

500 μL

2×1 mL

[Note]:  *IC: Internal control.

**PCS: Positive control solution,the concentration is 1,000 copies/µL.

***DNA Dilution buffer: used for IC dilution and the template of NTC and NCS.

****Ultrapure water: used for the preparation of qPCR Mix.

Storage

This product should be stored at -25~-15℃ for 2 years.

*Upon receipt of the kit, please check whether all components are complete and immediately store them in -25~-15℃ condition if not perform the assay immediately. Please note 40619-B should be stored away from light.

Application

Mycoplasma Detection; Mycoplasma Detection for BioProduction process media, cells, raw materials.

Figures

1. Workflow

Figure 1. Workflow of mycoplasma detection using the Mycoplasma Real-time Quantitative PCR Detection Kit

Figure 1. Workflow of mycoplasma detection using the Mycoplasma Real-time Quantitative PCR Detection Kit

2. Specificity

Figure 2. Specificity validation.

Figure 2. Specificity validation.

No.

Sample

Result

No.

Sample

Result

1

Staphylococcus epidermidis

Negative

11

Candida albicans

Negative

2

Clostridium perfringens

Negative

12

Salmonella enterica subsp. enterica

Negative

3

Clostridium acetobutylicum

Negative

13

Bacillus subtilis

Negative

4

Acinetobacter baumannii

Negative

14

Bacillus cereus

Negative

5

Lactobacillus acidophilus

Negative

15

HEK293 DNA

Negative

6

Enterobacter aerogenes

Negative

16

Vero DNA

Negative

7

Micrococcus luteus

Negative

17

CHO DNA

Negative

8

Streptococcus mutans

Negative

18

E. coli DNA

Negative

9

Pseudomonas aeruginosa

Negative

19

293T DNA

Negative

10

Streptococcus pneumoniae

Negative

20

SF9 DNA

Negative

Table 1. Results for 20 strains and engineered cell lines

(A). Nine common sample matrices and the kit’s DNA dilution buffer showed no mycoplasma detection in the target channel (FAM, blue). Normal FAM signal was observed only when Mycoplasma fermentans was added to a sample matrix.
(B). DNA from 14 non-Mycoplasmatales strains and 6 commonly used biopharmaceutical cell lines showed no target channel amplification. In all cases, the internal control channel (Cy5, green) amplified normally.

3. Limit of Detection (LOD): >95% detection rate.

Figure 3. Limit of detection (LOD) test.

Figure 3. Limit of detection (LOD) test.

Sample

FAM Ct

CY5 Ct

Interpretation

Mycoplasma arginini 10 CFU/mL

33.36

26.96

Positive

33.28

26.96

Positive

33.60

26.95

Positive

33.57

27.00

Positive

33.81

27.26

Positive

33.48

27.12

Positive

33.77

27.02

Positive

32.20

26.88

Positive

NCS

/

27.22

valid

NCS

/

27.32

valid

NTC

/

27.26

valid

NTC

/

26.92

valid

Table 2. Example detection results for Mycoplasma arginini

Ten mycoplasma standard strains (10 CFU/mL), sourced from German MB, were tested following kit instructions for nucleic acid extraction(Cat#18461) and detection kit(Cat#40619). Mycoplasma samples were tested three times with 8 replicates each. Each run included NCS (negative control solution) and NTC (no template control).

When controls passed, at least 23 out of 24 replicates tested positive for each strain.

4. Performance Validation Summary

Performance

Validation parameter

Kit validation result

Limit of detection

LOD for mycoplasma strains

10 pharmacopoeia-required mycoplasma strains at 10 CFU/mL, each tested 24 times; detection rate ≥ 95%

Specificity

Sample matrix interference

9 sample matrices and DNA dilution buffer tested — no mycoplasma detected

Specificity

Cross-reactivity

14 strains and 6 commonly used biopharmaceutical engineered cell lines tested — no mycoplasma detected

Robustness

Freeze-thaw stability

Withstands 20 repeated freeze-thaw cycles without affecting kit performance

Robustness

Heat-accelerated stability

14 days at 37°C and 30 days at 4°C without affecting kit performance

Robustness

Instrument compatibility

Compatible with ABI 7500, ABI QuantStudio™ 5, Bio-Rad CFX96, Roche LightCycler 480

Coverage

Mycoplasma DNA coverage

Database comparison based on mycoplasma 16S rRNA sequences; covers 183 species of the class Mollicutes

Table 3. Performance Validation Content and Conclusion of the Mycoplasma qPCR Detection Kit

Documents:

Safety Data Sheet

40619_MSDS_HB250814_EN.PDF

Manuals

40619_Manual_Ver.EN20250814.pdf

Related Blogs:

Co-publish papers: Establishment of Nucleic Acid Amplification Technology for the Detection of Mycoplasma in Biological Products. Molecules 2026, 31(11), 1794.

From Research to Regulatory Practice: Yeasen and NIFDC Advance NAT-Based Mycoplasma Testing for Biologics

MycAway Mycoplasma Real-time qPCR Detection Kit (2G) Validation Report

Fast, and Accurate Mycoplasma qPCR Kit

Concept of Mycoplasma and the Impact of Contamination

Mycoplasma qPCR detection and method validation contribute to the advancement of cell and gene therapy technology development

Payment & Security

American Express Apple Pay Diners Club Discover Google Pay Mastercard Visa

اطلاعات پرداخت شما با اطمینان پردازش می شود. ما جزئیات کارت اعتباری را ذخیره نمی کنیم و به اطلاعات کارت اعتباری شما دسترسی نداریم.

You may also like

Inquiry

FAQ

The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.

Certain applications may require additional third-party intellectual property rights.

Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.